CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 62 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $85,000 | +9.0% | 21,223 | 0.0% | 0.00% | – |
| Q4 2018 | $78,000 | -57.1% | 21,223 | 0.0% | 0.00% | – |
| Q3 2018 | $182,000 | -21.9% | 21,223 | 0.0% | 0.00% | – |
| Q2 2018 | $233,000 | +51.3% | 21,223 | +58.8% | 0.00% | – |
| Q1 2018 | $154,000 | +11.6% | 13,367 | 0.0% | 0.00% | – |
| Q4 2017 | $138,000 | -37.6% | 13,367 | -3.6% | 0.00% | – |
| Q3 2017 | $221,000 | +22.1% | 13,867 | -7.3% | 0.00% | – |
| Q2 2017 | $181,000 | +28.4% | 14,967 | +121.2% | 0.00% | – |
| Q1 2017 | $141,000 | +45.4% | 6,767 | 0.0% | 0.00% | – |
| Q4 2016 | $97,000 | -15.7% | 6,767 | -2.9% | 0.00% | – |
| Q3 2016 | $115,000 | +16.2% | 6,967 | 0.0% | 0.00% | – |
| Q2 2016 | $99,000 | – | 6,967 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $7,501,161 | 1.96% |
| TOWERVIEW LLC | 205,000 | $469,450 | 0.31% |
| Orbimed Advisors | 6,943,654 | $15,900,968 | 0.29% |
| CHI Advisors LLC | 200,000 | $458,000 | 0.14% |
| BVF INC/IL | 1,370,947 | $3,139,469 | 0.09% |
| SAMLYN CAPITAL, LLC | 2,105,930 | $4,822,580 | 0.08% |
| MYDA Advisors LLC | 100,000 | $229,000 | 0.07% |
| DIFESA CAPITAL MANAGEMENT, LP | 10,000 | $22,900 | 0.06% |
| JACKSON SQUARE CAPITAL, LLC | 63,773 | $146,040 | 0.06% |
| CORNERCAP INVESTMENT COUNSEL INC | 97,248 | $222,698 | 0.04% |